2 pharma firms to mine gene data from 500,000 Britons
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
London
BRITAIN'S GlaxoSmithKline and US-based Regeneron Pharmaceuticals are embarking on a joint project with UK Biobank, the world's most detailed biomedical database, to hunt for new clues linking genes and disease.
By analysing genetic variations and health in 500,000 middle-aged and older Britons, the partners said on Thursday that they hoped to identify promising leads for new medicines.
Share with us your feedback on BT's products and services
TRENDING NOW
Autobahn Rent A Car directors declared bankrupt over S$50 million each owed to DBS
Amazon’s MGM Studios gains creative control over ‘James Bond’ franchise
UOB’s Wee Ee Cheong says S$4.9 billion Citi deal ‘paying off’ as Asean push accelerates
In taxing wealth, how far can Singapore push property owners?
